198 related articles for article (PubMed ID: 29062340)
41. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
42. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
43. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
Lu KC; Ma WY; Yu JC; Wu CC; Chu P
Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
[TBL] [Abstract][Full Text] [Related]
44. Osteodystrophy in Indonesian haemodialysis patients.
Santoso D; Yogiantoro M; Tomino Y
Nephrology (Carlton); 2003 Oct; 8(5):261-5. PubMed ID: 15012715
[TBL] [Abstract][Full Text] [Related]
45. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
46. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
[TBL] [Abstract][Full Text] [Related]
47. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Scolari F; Cancarini GC; Maiorca R
Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
[TBL] [Abstract][Full Text] [Related]
48. Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Block GA; Zeig S; Sugihara J; Chertow GM; Chi EM; Turner SA; Bushinsky DA;
Nephrol Dial Transplant; 2008 Jul; 23(7):2311-8. PubMed ID: 18310602
[TBL] [Abstract][Full Text] [Related]
49. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of osteoporosis in otherwise healthy Indian males aged 50 years and above.
Agrawal NK; Sharma B
Arch Osteoporos; 2013; 8():116. PubMed ID: 23371477
[TBL] [Abstract][Full Text] [Related]
51. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
[TBL] [Abstract][Full Text] [Related]
52. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
53. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
Liangos O; Kirchhoff S; Buchholz J; Ketteler M
Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
[TBL] [Abstract][Full Text] [Related]
54. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
55. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women.
Mezquita-Raya P; Muñoz-Torres M; Luna JD; Luna V; Lopez-Rodriguez F; Torres-Vela E; Escobar-Jiménez F
J Bone Miner Res; 2001 Aug; 16(8):1408-15. PubMed ID: 11499863
[TBL] [Abstract][Full Text] [Related]
56. Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China.
Tao S; Li X; Liu Z; Bai Y; Qian G; Wu H; Li J; Guo Y; Yang S; Chen L; Yang J; Han J; Ma S; Yang J; Yu L; Shui R; Jin X; Wang H; Zhang F; Chen T; Li X; Zong X; Liu L; Fan J; Wang W; Zhang Y; Shi G; Wang D
Int Urol Nephrol; 2023 Feb; 55(2):389-398. PubMed ID: 35951256
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
58. Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.
Yang ZK; Ying C; Zhao HY; Fang YH; Chen Y; Shen WF
J Zhejiang Univ Sci B; 2015 May; 16(5):362-9. PubMed ID: 25990053
[TBL] [Abstract][Full Text] [Related]
59. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
[TBL] [Abstract][Full Text] [Related]
60. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.
Floege J; Kim J; Ireland E; Chazot C; Drueke T; de Francisco A; Kronenberg F; Marcelli D; Passlick-Deetjen J; Schernthaner G; Fouqueray B; Wheeler DC;
Nephrol Dial Transplant; 2011 Jun; 26(6):1948-55. PubMed ID: 20466670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
